With new access levers emerging, positioning products will require a shift form the traditional launch playbook.
Bart Lombardi
Advertisement
Bart Lombardi is a founder and managing director of Clarion, a Life Sciences Consultancy.
Articles by Bart Lombardi
In 2020 and beyond, succeeding in the new ecosystem means focusing on delivering value backed by data, tailored engagements with a diverse range of distinctly defined stakeholders, and monitoring the rapidly evolving healthcare space for new trends that will impact success.
Advertisement
Latest Updated Articles
Launch Strategies: What You Need to Know in 2020Published: April 8th 2020 | Updated:
Product Launch Strategies: Adapting Approaches in 2020 and BeyondPublished: June 1st 2020 | Updated:
Advertisement
Advertisement
Trending on PharmExec
1
Report: Richard Pazdur Out as Director of CDER
2
FDA Appoints Tracy Beth Høeg as Acting Director of CDER
3
Regeneron Announces $150 Million Collaboration with Tessera Therapeutics to Develop Gene Editing Therapy
4
Lilly Reduces Price of Zepbound Single-Dose Vials for Self-Pay Patients
5
